We are live on ! Find out more
SLXNW

Silexion Therapeutics Warrant
SLXNW

19 hedge funds and large institutions have $62K invested in Silexion Therapeutics Warrant in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.54% less ownership

Funds ownership: 39.93% → 39.39% (-0.54%)

14% less funds holding

Funds holding: 22 → 19 (-3)

25% less capital invested

Capital invested by funds: $83.1K → $62K (-$21.1K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
19
Holders Change
-3
Holders Change %
-13.64%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
3
Calls
$18K
Puts
–
Net Calls
+$18K
Net Calls Change
-$10K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$71

Top Sellers

Rank Fund Capital Flow
1
BOCH
Blue Owl Capital Holdings
New York
-$375
2
CS
Clear Street
New York
-$6
3
Bank of America
Bank of America
North Carolina
-$3
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
1
Polar Asset Management Partners
Ontario, Canada
$15.9K – – –
OMC
2
Oasis Management Company
Cayman Islands
$14.2K – – –
LA
3
Linden Advisors
New York
$7.22K – – –
AC
4
Aristeia Capital
Connecticut
$5.05K – – –
CS
5
Clear Street
New York
$4.44K -$6 -200 -0.1%
Goldman Sachs
6
Goldman Sachs
New York
$2.51K +$71 +2,257 +2%
KC
7
Kepos Capital
New York
$2K – – –
SBLIC
8
Security Benefit Life Insurance Company
Kansas
$1.88K – – –
Jane Street
9
Jane Street
New York
$1.52K – – –
PMAM
10
Picton Mahoney Asset Management
Ontario, Canada
$1.16K – – –
CCM
11
Context Capital Management
California
$1.04K – – –
TCM
12
Tenor Capital Management
New York
$1.01K – – –
MTCM
13
Mint Tower Capital Management
Netherlands
$1K – – –
GCIA
14
Gabelli & Co Investment Advisers
New York
$774 – – –
Neuberger Berman Group
15
Neuberger Berman Group
New York
$641 – – –
GF
16
Gabelli Funds
New York
$619 – – –
DCM
17
Dupont Capital Management
Delaware
$406 – – –
Stifel Financial
18
Stifel Financial
Missouri
$325 – – –
SCM
19
Saba Capital Management
New York
$242 – – –
BOCH
20
Blue Owl Capital Holdings
New York
– -$375 -12,500 Closed
Bank of America
21
Bank of America
North Carolina
– -$3 -100 Closed

SLXNW Hedge Fund Activity: Q1 2026 in Review

19 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Silexion Therapeutics Warrant (SLXNW) for Q1 2026, worth a combined $62K — down 25% from $83.1K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SLXNW and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Goldman Sachs, adding an estimated $71. The largest seller was Blue Owl Capital Holdings, exiting entirely with an estimated $375 sold.

  • 19 institutional investors held Silexion Therapeutics Warrant (SLXNW) as of Q1 2026, down from 22 in Q4 2025.
  • Funds reported $62K of Silexion Therapeutics Warrant stock for Q1 2026, down 25% quarter-over-quarter.
  • 0 funds opened new Silexion Therapeutics Warrant positions in Q1 2026 and 3 closed out, a net change of -3 holders.
  • The largest Silexion Therapeutics Warrant buyer in Q1 2026 was Goldman Sachs, an estimated $71 added.
  • The largest Silexion Therapeutics Warrant seller in Q1 2026 was Blue Owl Capital Holdings, an estimated $375 sold.

Based on aggregated 13F filings for Q1 2026.